bearish
SINOPHARM (1099 HK): Not What It Seems
200 Views27 Sep 2017 16:57
Sinopharm has misrepresented its cash flow statement and aggressively window dressed its balance sheet. The company appears to have persuaded its...
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 8-minute read)
Discussions
(Paid Plans Only)
GMT Research
The accounting research firm
Price Chart(Sign Up to Access)
- Sinopharm (国医控股) Placement - Unattractive but Inexpensive16 Jan 2020
- Sinopharm (1099 HK): Top Distributor of Pharma Products in China24 May 2018
- SINOPHARM (1099 HK): Not What It Seems27 Sep 2017
x